IDEAYA Biosciences (IDYA)
(Real Time Quote from BATS)
$40.33 USD
-0.32 (-0.79%)
Updated Apr 30, 2024 11:42 AM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.53 |
EPS Last Quarter | -0.52 |
Last EPS Surprise | -6.12% |
ABR | 1.09 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.26 |
Next Year | -2.63 |
EPS (TTM) | -1.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.20M | 5.80M | 22.00M | 33.47M |
# of Estimates | 5 | 5 | 6 | 4 |
High Estimate | 8.00M | 8.00M | 32.00M | 57.48M |
Low Estimate | 5.00M | 3.00M | 7.00M | 20.00M |
Year ago Sales | 7.88M | 3.54M | 23.39M | 22.00M |
Year over Year Growth Est. | -21.32% | 63.84% | -5.92% | 52.14% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.53 | -0.54 | -2.26 | -2.63 |
# of Estimates | 7 | 7 | 7 | 7 |
Most Recent Consensus | -0.54 | -0.57 | -2.45 | -3.16 |
High Estimate | -0.44 | -0.43 | -1.82 | -1.85 |
Low Estimate | -0.63 | -0.65 | -2.64 | -3.16 |
Year ago EPS | -0.49 | -0.50 | -1.96 | -2.26 |
Year over Year Growth Est. | -8.16% | -8.00% | -15.31% | -16.24% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.53 | -0.54 | -2.26 | -2.63 |
7 Days Ago | -0.53 | -0.54 | -2.26 | -2.63 |
30 Days Ago | -0.53 | -0.54 | -2.26 | -2.63 |
60 Days Ago | -0.53 | -0.54 | -2.26 | -2.63 |
90 Days Ago | -0.60 | -0.61 | -2.40 | -2.72 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.53 | -0.54 | -2.26 | -2.63 |
Zacks Consensus Estimate | -0.53 | -0.54 | -2.26 | -2.63 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.52 | -0.46 | -0.50 | -0.49 | NA |
Estimate | -0.49 | -0.47 | -0.53 | -0.51 | NA |
Difference | -0.03 | 0.01 | 0.03 | 0.02 | 0.01 |
Surprise | -6.12% | 2.13% | 5.66% | 3.92% | 1.40% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more